GEHC stock forecast: what analysts expect
Wall Street analysts covering GE HealthCare Technologies Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $82.50 — +14.1% versus the last price of $72.28. Targets reflect analyst opinion, not a guarantee.
GEHC historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in GEHC.
GEHC annual returns by year
Congress trading in GEHC
3 members of Congress have disclosed trading GEHC — 2 purchases and 2 sales worth an estimated $40,000. Most recent disclosure: Mar 23, 2026.
Insider activity in GEHC
GEHC's own executives and directors have made 1 open-market purchase ($641,800) and 0 sales ($0) in the last 90 days, per SEC Form 4 filings. Most recent: May 22, 2026.
| May 22, 2026 | Lobo Kevin | Director | Buy | $641,800 |
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GEHC Key Statistics
GEHC in plain English
- P/E ratio (16.7) — how many dollars you pay for each $1 of GEHC's yearly profit. That's a fairly normal range.
- ROE (19.38%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (9.33%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.19%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
GEHC stock: frequently asked questions
What is GE HealthCare Technologies Inc.'s stock price today?
GE HealthCare Technologies Inc. (GEHC) last traded at $72.28 on the NASDAQ. Over the past 52 weeks the stock has traded between $58.75 and $89.77.
Is GEHC stock a buy or a sell?
Wall Street analysts' consensus rating on GEHC is "Buy", with an average 12-month price target of $82.50 — about +14.1% versus the current price of $72.28. Analyst targets are opinions, not guarantees; always do your own research.
Does GEHC pay a dividend?
Yes. GE HealthCare Technologies Inc. currently pays a dividend yielding about 0.19% per year at today's share price.
What is GEHC's P/E ratio?
GEHC trades at a trailing price-to-earnings ratio of 16.7, and 13.4 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade GEHC stock?
Yes — 3 members of Congress have disclosed trades in GEHC under the STOCK Act, totaling 2 purchases and 2 sales worth an estimated $40,000.
What is GE HealthCare Technologies Inc.'s ticker symbol?
GE HealthCare Technologies Inc. trades under the ticker symbol GEHC on the NASDAQ.
Compare GEHC with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.